TABLE OF CONTENTS
Volume 26, Issue 37 (13 August 2007)
Guest Editors
Top of pageIntroduction
HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention
X-J Yang and E Seto
Oncogene 26: 5310-5318; doi:10.1038/sj.onc.1210599
Reviews
Hat1: the emerging cellular roles of a type B histone acetyltransferase
M R Parthun
Oncogene 26: 5319-5328; doi:10.1038/sj.onc.1210602
The SAGA continues: expanding the cellular role of a transcriptional co-activator complex
S P Baker and P A Grant
Oncogene 26: 5329-5340; doi:10.1038/sj.onc.1210603
Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation
Z Nagy and L Tora
Oncogene 26: 5341-5357; doi:10.1038/sj.onc.1210604
Orchestration of chromatin-based processes: mind the TRRAP
R Murr, T Vaissière, C Sawan, V Shukla and Z Herceg
Oncogene 26: 5358-5372; doi:10.1038/sj.onc.1210605
MYST opportunities for growth control: yeast genes illuminate human cancer gene functions
A Lafon, C S Chang, E M Scott, S J Jacobson and L Pillus
Oncogene 26: 5373-5384; doi:10.1038/sj.onc.1210606
Males absent on the first (MOF): from flies to humans
S Rea, G Xouri and A Akhtar
Oncogene 26: 5385-5394; doi:10.1038/sj.onc.1210607
The MYST family of histone acetyltransferases and their intimate links to cancer
N Avvakumov and J Côté
Oncogene 26: 5395-5407; doi:10.1038/sj.onc.1210608
MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells
X-J Yang and M Ullah
Oncogene 26: 5408-5419; doi:10.1038/sj.onc.1210609
Histone deacetylases and cancer
M A Glozak and E Seto
Oncogene 26: 5420-5432; doi:10.1038/sj.onc.1210610
The human Mi-2/NuRD complex and gene regulation
S A Denslow and P A Wade
Oncogene 26: 5433-5438; doi:10.1038/sj.onc.1210611
HDAC3: taking the SMRT-N-CoRrect road to repression
P Karagianni and J Wong
Oncogene 26: 5439-5449; doi:10.1038/sj.onc.1210612
Class IIa histone deacetylases: regulating the regulators
M Martin, R Kettmann and F Dequiedt
Oncogene 26: 5450-5467; doi:10.1038/sj.onc.1210613
HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination
C Boyault, K Sadoul, M Pabion and S Khochbin
Oncogene 26: 5468-5476; doi:10.1038/sj.onc.1210614
Arabidopsis histone deacetylase 6: a green link to RNA silencing
W Aufsatz, T Stoiber, B Rakic and K Naumann
Oncogene 26: 5477-5488; doi:10.1038/sj.onc.1210615
Sirtuins: critical regulators at the crossroads between cancer and aging
L R Saunders and E Verdin
Oncogene 26: 5489-5504; doi:10.1038/sj.onc.1210616
NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs
A Vaquero, R Sternglanz and D Reinberg
Oncogene 26: 5505-5520; doi:10.1038/sj.onc.1210617
Structure and acetyl-lysine recognition of the bromodomain
S Mujtaba, L Zeng and M-M Zhou
Oncogene 26: 5521-5527; doi:10.1038/sj.onc.1210618
Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design
S C Hodawadekar and R Marmorstein
Oncogene 26: 5528-5540; doi:10.1038/sj.onc.1210619
